The Evidence Grading Framework
Each supplement below is assessed using a consistent framework:
- Mechanism: Does the supplement have a plausible physiological mechanism for fat loss?
- Evidence quality: Is there evidence from randomised controlled trials (RCTs) in humans?
- Effect size: How much additional weight loss does the evidence support beyond diet and exercise alone?
- Safety profile: Are there known risks, contraindications, or long-term safety concerns?
The honest conclusion from reviewing the literature: no supplement produces clinically meaningful fat loss comparable to a well-maintained calorie deficit. The supplements with genuine evidence produce modest effects — typically 0.5–2 kg of additional weight loss over 12 weeks in the best studies. No supplement replaces dietary control or physical activity.
Supplements With Genuine Evidence
| Supplement | Mechanism | Evidence quality | Effect size | Verdict |
|---|---|---|---|---|
| Caffeine | Increases resting metabolic rate; enhances fat oxidation during exercise; mild appetite suppression | Strong (many RCTs) | ~50–100 kcal/day additional expenditure; modest appetite reduction | ✅ Useful adjunct |
| Protein powder | Facilitates meeting protein targets (the most satiating macronutrient); TEF effect; muscle preservation | Strong (indirect evidence via protein meta-analyses) | Significant when used to reach protein targets that food alone does not cover | ✅ Useful if protein deficit |
| Psyllium husk / soluble fibre | Slows gastric emptying; stimulates GLP-1 and PYY satiety hormones; reduces calorie absorption | Moderate (multiple RCTs) | ~1–2 kg additional weight loss at 12 weeks vs placebo | ✅ Modest benefit |
| Green tea extract (EGCG + caffeine) | EGCG inhibits catechol-O-methyltransferase (COMT), extending norepinephrine effect; caffeine synergy | Moderate (meta-analyses) | ~1.2 kg additional weight loss over 12 weeks (Hursel meta-analysis) | ⚠️ Modest; effect likely mainly from caffeine |
| Glucomannan (konjac fibre) | Highly viscous soluble fibre; expands in stomach; delays gastric emptying significantly | Moderate (several RCTs) | ~1–2 kg additional weight loss; significant appetite reduction in some studies | ⚠️ Modest benefit; must be taken with adequate water |
Based on: Hursel R, Viechtbauer W, Westerterp-Plantenga MS. "The effects of green tea on weight loss and weight maintenance: a meta-analysis." Int J Obes (Lond). 2009;33(9):956–961. PubMed ↗
Popular Supplements With Weak or No Evidence
The following supplements are widely marketed for weight loss but have no credible clinical evidence for meaningful fat loss in healthy adults, or have evidence so weak or confounded that a reliable effect cannot be established:
- Raspberry ketones: No credible human RCT evidence for fat loss. Studies are in animals or in vitro. Mechanism (ketone production from raspberry extract) is pharmacologically implausible at supplemental doses.
- Garcinia cambogia (HCA): Multiple systematic reviews find no significant weight loss vs placebo in well-designed RCTs. Studies showing positive results are typically small, short, and poorly controlled.
- "Fat burner" blends: Proprietary blends of multiple stimulants (synephrine, yohimbine, capsaicin, B vitamins, chromium) with claimed metabolic effects. Any effect present is from caffeine content. No evidence for the combination producing synergistic fat loss.
- CLA (conjugated linoleic acid): Small effects on body fat in some studies (~0.09 kg/week in meta-analyses), possibly through modest alterations to lipid metabolism. Effect size is clinically insignificant and does not justify supplementation cost.
- Detox teas and cleanse products: No physiological mechanism for fat loss. Any weight change is from laxative effect (water and stool weight loss, not fat). Some products contain undisclosed stimulants or laxatives (senna) not disclosed on labels.
Based on: Onakpoya I, Hung SK, Perry R, Wider B, Ernst E. "The use of Garcinia extract (hydroxycitric acid) as a weight loss supplement: a systematic review and meta-analysis of randomised clinical trials." J Obes. 2011;2011:509038. PubMed ↗